About Alcon AG
Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives.
Alcon AG (ALC) Stock Score & Signals
Alcon AG (ALC) trades on NYSE. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 41 out of 100.
2BB score and signals
Alcon AG’s current 2BB score is 41 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 26 | Low |
| Momentum | 50 | Stable |
| Financial strength | 74 | Strong |
| Quality | 97 | Very Strong |
| Risk | 35 | Low (provisional) |
Company facts
| CEO | David J. Endicott |
| Headquarters | Geneva, Geneva, Switzerland |
| Founded | 1945 |
| Employees | 25K |
| 52-week range | $61.84 – $87.64 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-22 | — | 0.947 | — | $2.87B |
| 2026-11-10 | — | 0.883 | — | $2.77B |
| 2026-08-10 | — | 0.7601 | — | $2.80B |